Core Services
Accurate comparator selection. Compliant sourcing. Reliable delivery.
Ikris Pharma Network provides specialized RLD sourcing services in India, supporting pharmaceutical companies, CROs, and research teams in sourcing authentic Reference Listed Drugs (RLDs) and comparator drugs from regulated markets, including the USA, Europe, and the UK.
With 12+ years of experience, we ensure compliant procurement, complete documentation, and temperature-controlled delivery aligned with clinical and regulatory requirements.
RLD sourcing services involve procuring Reference Listed Drugs (RLDs) or comparator drugs from regulated markets for use in bioequivalence (BA/BE) studies, clinical trials, and drug development.
Selecting the correct RLD — typically listed in sources such as the US FDA Orange Book or EMA-approved product lists — is critical to ensure:
Whether you need comparator drugs for clinical trials, BA/BE studies, or drug development — accurate sourcing is critical. Avoid costly delays and ensure regulatory acceptance from Day 1.
Comprehensive services designed to support every stage of your clinical and regulatory journey — from comparator selection to final delivery.
As a trusted RLD supplier in India, Ikris Pharma Network combines global sourcing access with a deep understanding of regulatory and clinical requirements. Ensuring your comparator sourcing aligns with protocol, compliance, and timelines.
A single sourcing error can lead to:
Regulatory rejection due to the incorrect comparator
Import delays from incomplete documentation
Product compromise from cold-chain failure
Study risks from unverified suppliers
Your study success depends on sourcing the right RLD from the right market.
Every shipment is backed with:
Ensuring full compliance for clinical trials and BA/BE studies in India.
Molecule | Strength | Market | Quantity
Sourced from regulated markets within 24 hours
Complete, study-ready documentation
Temperature-controlled shipment to your site
Whether you need comparator drugs for clinical trials, BA/BE studies, or drug development, accurate sourcing is critical. Avoid costly delays and ensure regulatory acceptance from Day 1.
RLD sourcing services in India involve procuring Reference Listed Drugs (RLDs) from regulated markets such as the USA, Europe, and the UK for use in clinical trials, BA/BE studies, and drug development.
Comparator drugs can be sourced through specialized RLD sourcing companies like Ikris Pharma Network. We source RLDs from regulated markets and provide compliant procurement, documentation, and delivery aligned with clinical study requirements.
Yes, RLD drugs can be imported into India under regulatory provisions with proper documentation, approvals, and compliance with applicable import guidelines.
Typically, verified availability and pricing can be provided within 24 hours, while delivery timelines depend on the source market, documentation, and logistics requirements.
Common documents include Certificate of Analysis (COA), Pedigree, Invoice, and Packing List.
Using the correct RLD ensures regulatory acceptance, accurate study results, and avoids delays or rejection in drug approval processes.
Get in Touch with Our Team
Looking for a reliable partner for pharmaceutical exports from India or Reference Listed Drug (RLD) services? Ikris Pharma Network combines regulatory expertise, verified sourcing, and a precision-driven supply process to meet your requirements with confidence.
Submit your requirement today and receive a prompt response from our specialists.
Mail Us Now
Office Address
905, I-Thum Business Park, Plot No. A-40, Unit No. 5, Tower A, Sector-62, Noida – 201301 (India)